ATE417106T1 - Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon - Google Patents

Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon

Info

Publication number
ATE417106T1
ATE417106T1 AT00908862T AT00908862T ATE417106T1 AT E417106 T1 ATE417106 T1 AT E417106T1 AT 00908862 T AT00908862 T AT 00908862T AT 00908862 T AT00908862 T AT 00908862T AT E417106 T1 ATE417106 T1 AT E417106T1
Authority
AT
Austria
Prior art keywords
dna fragments
chlamydia
corresponding dna
strain
host
Prior art date
Application number
AT00908862T
Other languages
German (de)
English (en)
Inventor
Andrew Murdin
Raymond Oomen
Joe Wang
Pamela Dunn
Original Assignee
Aventis Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur filed Critical Aventis Pasteur
Application granted granted Critical
Publication of ATE417106T1 publication Critical patent/ATE417106T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
AT00908862T 1999-03-12 2000-03-09 Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon ATE417106T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12396699P 1999-03-12 1999-03-12

Publications (1)

Publication Number Publication Date
ATE417106T1 true ATE417106T1 (de) 2008-12-15

Family

ID=22411985

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00908862T ATE417106T1 (de) 1999-03-12 2000-03-09 Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon

Country Status (10)

Country Link
US (3) US7183402B2 (fr)
EP (2) EP1163342B1 (fr)
JP (1) JP4832646B2 (fr)
AT (1) ATE417106T1 (fr)
AU (1) AU775695B2 (fr)
CA (1) CA2365196C (fr)
DE (1) DE60041042D1 (fr)
MX (1) MXPA01009256A (fr)
NZ (1) NZ514140A (fr)
WO (1) WO2000055326A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9513371D0 (en) * 1995-06-30 1995-09-06 Biocine Spa Immunogenic detoxified mutant toxins
CA2366462C (fr) * 1998-12-04 2011-08-09 University Of Manitoba Procedure d'immunisation en deux etapes contre l'infection parchlamydia
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
WO2001036456A2 (fr) * 1999-11-15 2001-05-25 Aventis Pasteur Limited Antigenes de chlamydia, fragments d'adn correspondants et leurs utilisations
CA2395499C (fr) * 1999-12-22 2011-10-25 Aventis Pasteur Limited Antigenes anti-chlamydia, fragments d'adn correspondants et leurs utilisations
GB0227346D0 (en) * 2002-11-22 2002-12-31 Chiron Spa 741
EP3156068B1 (fr) * 2010-03-29 2021-11-03 CNRS (Centre National de la Recherche Scientifique) Compositions pharmaceutiques comprenant un polypeptide comprenant au moins un motif cxxc et des antigènes hétérologues et leurs utilisations
US8664843B2 (en) * 2010-04-02 2014-03-04 Ngk Spark Plug Co., Ltd. Spark plug
JP7086000B2 (ja) 2015-11-10 2022-06-17 オハイオ・ステート・イノヴェーション・ファウンデーション 体液性親和性の加速に関する方法及び組成物
US11185555B2 (en) 2016-04-11 2021-11-30 Noah James Harrison Method to kill pathogenic microbes in a patient

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879213A (en) 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
US5837268A (en) * 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
US5776746A (en) 1996-05-01 1998-07-07 Genitope Corporation Gene amplification methods
US6210876B1 (en) * 1996-06-06 2001-04-03 Abbott Laboratories Nucleic acid primers and probes for detecting Chlamydia pneumoniae
US20020044949A1 (en) * 1997-04-01 2002-04-18 Harold Kleanthous 76 kda helicobacter polypeptides and corresponding polynucleotide molecules
US6020191A (en) 1997-04-14 2000-02-01 Genzyme Corporation Adenoviral vectors capable of facilitating increased persistence of transgene expression
CA2294651A1 (fr) * 1997-06-23 1998-12-30 Svend Birkelund Nouvelles proteines de membrane externe issues de chlamydia pneumoniae
DE69836977T2 (de) 1997-11-21 2007-10-18 Serono Genetics Institute S.A. Chlamydia pneumoniae genomische sequenzen und polypeptiden, fragmenten und anwendungen davon für nachweis, prevention und heilung
DE69841894D1 (de) 1997-11-21 2010-10-21 Merck Serono Biodevelopment Sa Äusseres Membranpolypeptid von Chlamydia pneumoniae sowie Fragmente davon und deren Verwendung, insbesondere zur Diagnose, Prävention und Behandlung einer Infektion
EP2228384A1 (fr) 1997-11-28 2010-09-15 Merck Serono Biodevelopment Séquence génomique de Chlamydia pneumoniae, polypeptides, fragments et leurs utilisations, en particulier pour le diagnostic, la prévention et le traitement de l'infection
US6693087B1 (en) 1998-08-20 2004-02-17 Aventis Pasteur Limited Nucleic acid molecules encoding POMP91A protein of Chlamydia
CA2340330A1 (fr) 1998-08-20 2000-03-02 Aventis Pasteur Limited Molecules d'acide nucleique codant la proteine membrane d'inclusion c de chlamydia
CA2342837A1 (fr) 1998-09-15 2000-03-23 Yale University Long segment terminal artificiel a repetitions
WO2000024765A2 (fr) 1998-10-28 2000-05-04 Aventis Pasteur Limited Antigenes de chlamydia, fragments d'adn correspondant et leurs utilisations
US6822071B1 (en) 1998-11-12 2004-11-23 The Regents Of The University Of California Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease
JP2002529069A (ja) 1998-11-12 2002-09-10 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア クラミジア・ニューモニエのゲノム配列
CA2353107A1 (fr) 1998-12-01 2000-06-08 Andrew D. Murdin Antigenes de chlamydia et fragments d'adn correspondants et leur utilisation
EP2277893A3 (fr) 1998-12-08 2011-03-30 Corixa Corporation Composés et procédés pour le traitement et le diagnostic des infections à chlamydia
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US6565856B1 (en) 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
US6808713B1 (en) 1998-12-28 2004-10-26 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
GB9902555D0 (en) 1999-02-05 1999-03-24 Neutec Pharma Plc Medicament
WO2000066739A2 (fr) 1999-05-03 2000-11-09 Aventis Pasteur Limited Antigenes de chlamydia, fragments d'adn correspondants et utilisation de ceux-ci
CA2385325C (fr) 1999-09-20 2012-04-10 Aventis Pasteur Limited Antigenes de chlamydia, fragments d'adn correspondants et utilisations
US6632663B1 (en) 1999-09-22 2003-10-14 Aventis Pasteur Limited DNA immunization against chlamydia infection
BR0017020A (pt) * 1999-12-15 2003-01-07 Univation Tech Llc Processo de polimerização
CA2395499C (fr) 1999-12-22 2011-10-25 Aventis Pasteur Limited Antigenes anti-chlamydia, fragments d'adn correspondants et leurs utilisations
WO2001046225A2 (fr) 1999-12-22 2001-06-28 Aventis Pasteur Limited Antigenes anti-chlamydia, fragments d'adn correspondants et leurs utilisations
EP1275704B1 (fr) * 2000-04-03 2006-09-06 MITSUBISHI PENCIL Co., Ltd. Composition d'encre de stylo bille a base d'huile et stylo bille a encre a base d'huile
US20020132994A1 (en) 2000-04-04 2002-09-19 Murdin Andrew D. Chlamydia antigens and corresponding DNA fragments and uses thereof
US20020071831A1 (en) 2000-04-04 2002-06-13 Murdin Andrew D. Chlamydia antigens and corresponding DNA fragments and uses thereof
US20020082402A1 (en) 2000-04-04 2002-06-27 Murdin Andrew D. Chlamydia antigens and corresponding DNA fragments and uses thereof
US20020094965A1 (en) 2000-04-04 2002-07-18 Murdin Andrew D. Chlamydia antigens and corresponding DNA fragments and uses thereof
US20030100706A1 (en) 2000-04-04 2003-05-29 Murdin Andrew D. Chlamydia antigens and corresponding DNA fragments and uses thereof
US20030175700A1 (en) 2000-04-21 2003-09-18 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US20040254130A1 (en) 2000-05-08 2004-12-16 Murdin Andrew D Chlamydia antigens and corresponding dna fragments and uses thereof
ATE348892T1 (de) 2000-05-08 2007-01-15 Sanofi Pasteur Ltd Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
EP2166019A3 (fr) 2000-07-03 2010-06-09 Novartis Vaccines and Diagnostics S.r.l. Immunisation contre Chlamydia pneumoniae
US6706274B2 (en) 2001-01-18 2004-03-16 Scimed Life Systems, Inc. Differential delivery of nitric oxide
US7061245B2 (en) * 2004-02-06 2006-06-13 Snap-On Incorporated Coil-on plug capacitive sensors and passive coil-on plug diagnostic system incorporating same

Also Published As

Publication number Publication date
JP2002538825A (ja) 2002-11-19
EP1163342B1 (fr) 2008-12-10
US20050186266A1 (en) 2005-08-25
MXPA01009256A (es) 2003-07-14
DE60041042D1 (de) 2009-01-22
US20080113933A1 (en) 2008-05-15
US20050069942A1 (en) 2005-03-31
EP2172214A2 (fr) 2010-04-07
US7183402B2 (en) 2007-02-27
US7285276B2 (en) 2007-10-23
CA2365196C (fr) 2011-11-15
CA2365196A1 (fr) 2000-09-21
JP4832646B2 (ja) 2011-12-07
EP1163342A1 (fr) 2001-12-19
US7629327B2 (en) 2009-12-08
AU3138300A (en) 2000-10-04
EP2172214A3 (fr) 2011-03-16
NZ514140A (en) 2001-09-28
WO2000055326A1 (fr) 2000-09-21
AU775695B2 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
WO2000066739A3 (fr) Antigenes de chlamydia, fragments d'adn correspondants et utilisation de ceux-ci
WO2001046224A3 (fr) Antigenes anti-chlamydia, fragments d'adn correspondants et leurs utilisations
WO2001070174A8 (fr) Genes modules par vegf et leurs procedes d'utilisation
ATE384793T1 (de) Chlamydia antigene und entsprechende dna- fragmente und ihre verwendungen
DE60120621D1 (de) Lawsonia intracellularis Impfstoff
ATE348892T1 (de) Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
ATE417106T1 (de) Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon
WO2001046225A3 (fr) Antigenes anti-chlamydia, fragments d'adn correspondants et leurs utilisations
WO2001075112A3 (fr) Antigene chlamydia, fragments d'adn correspondants, et leurs utilisations
WO2001075111A3 (fr) Antigenes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci
WO2001075113A3 (fr) Antigenes de chlamydia, fragments correspondants d'adn, et leurs utilisations
WO2001074863A3 (fr) Antigenes de chlamydia, fragments d'adn correspondants, et utilisations desdits fragments
WO2001075114A3 (fr) Antigenes de $i(chlamydia) et fragments d'adn correspondants, et leur utilisation
DK1536006T3 (da) Cancerantigener og anvendelse deraf
WO2001046226A3 (fr) Antigenes de chlamydia, fragments d'adn correspondants et utilisations de ceux-ci
DK1274853T3 (da) Materialer og fremgangsmåder, der angår immunreaktioner på fusionsproteiner
WO2005026200A3 (fr) Vaccin sous-unite contre lawsonia intracellularis
WO2000006742A3 (fr) Antigenes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci
MXPA01004353A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
WO2000026239A3 (fr) Antigenes de chlamydia et fragments d'adn correspondants et leurs utilisations
WO2000011183A3 (fr) Antigenes de chlamydia, fragments d'adn correspondants et leur utilisation
DE69925927D1 (de) Mutmassliches 98 kd protein des aussenmembrans von chlamydia und dafür kodierende dns sowie deren verwendung
WO2001036455A3 (fr) Antigenes de chlamydia, fragments d'adn correspondants et leurs utilisations
WO2000006743A3 (fr) Antigenes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci
WO2000006739A3 (fr) Antigenes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1163342

Country of ref document: EP